New Product Market Launch Roadmap for the Fiscal Year Ending June 2024
First written in FY2023. 1 of 6 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025AdvancedAnnual report
「Sales of the glycan profiling system LuBEA-Ⅷ began on 1 July 2025,」
Regarding the new-product launch plan, the specific launch achievement of beginning sales of LuBEA-Ⅷ was recorded as of 1 July 2025. - FY2024Delay in launching new productsAnnual report
「In sales of branded products, the decline in the number of PCR tests following the subsiding of the COVID-19 pandemic and delays in launching new products in the market」
The delay in launching branded products against the new-product market launch roadmap was cited as a factor behind the decline in revenue. - FY2024-Q3The new-product launch plan was made concrete as 4 models to be launched in the third and fourth quarters.Annual report
「For our branded equipment, sales of which declined as the COVID-19 pandemic subsided, we will expand sales by launching a total of 4 new products in the third and fourth quarters.」
The plan changed from launching 3 models in the third quarter, as presented in FY2024-Q2, to launching a total of 4 models in the third and fourth quarters, making the launch timing and number of products more concrete. - FY2024-Q2A plan to launch 3 models in the third quarter was explicitly stated.Annual report
「For our branded equipment, sales of which have declined as the COVID-19 pandemic has subsided, we will expand sales by launching 3 new products in the third quarter.」
In addition to the existing new-product launch roadmap, a sales recovery measure for branded equipment was presented, specifying both the timing and number of products, with 3 models to be launched in the third quarter. - FY2024-Q1RestatedAnnual report
「Under these circumstances, as a biotechnology venture, our group is pursuing new product development based on the market-launch roadmap, considering new testing businesses, and reforming our business operations.」
Development based on the new-product launch roadmap presented in FY2023 continues to move forward. - FY2023First statedAnnual report
「To shore up sales in the 39th fiscal year, we plan to launch new products, including the Pressure Ulcer Prevention Mat (Sasakaze), the new magLEAD12gCLINK and geneLEADXXⅣ.」
As a sales recovery measure for the 39th fiscal year, the plan to launch the Pressure Ulcer Prevention Mat, the new magLEAD12gCLINK and geneLEAD XXIV was newly made concrete.